Regulon: R-842
Regulons
are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.
Regulon Summary
Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio
, its Regulator
, the Transcriptional Program
that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.
Genes | Cox Hazard Ratio | Regulators | Causal Flows | Transcriptional Programs | Hallmarks |
---|---|---|---|---|---|
12 | -0.646848 | 1 | 0 | Pr-122 | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Regulon Genes
List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator
of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.
Entrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
---|---|---|---|
3674 | ENSG00000005961 | ITGA2B | P08514 |
26998 | ENSG00000090512 | FETUB | Q9UGM5 |
1053 | ENSG00000092067 | CEBPE | Q15744 |
959 | ENSG00000102245 | CD40LG | P29965 |
2250 | ENSG00000138675 | FGF5 | P12034 |
939 | ENSG00000139193 | CD27 | P26842 |
2264 | ENSG00000160867 | FGFR4 | P22455 |
5731 | ENSG00000160951 | PTGER1 | P34995 |
2672 | ENSG00000162676 | GFI1 | Q99684 |
253512 | ENSG00000174032 | SLC25A30 | Q5SVS4 |
2300 | ENSG00000176678 | FOXL1 | Q12952 |
6693 | ENSG00000197471 | SPN | P16150 |
Regulon Drugs
Name | Approved Symbol | Type | Action Type | Mechanism of Action | Max Trial Phase | Max GBM Phase |
---|---|---|---|---|---|---|
ALPROSTADIL | PTGER2 | Small molecule | AGONIST | Prostanoid EP1 receptor agonist | 4 | 0 |
BRIVANIB ALANINATE | KDR | Small molecule | INHIBITOR | Vascular endothelial growth factor receptor inhibitor | 3 | 0 |
ERDAFITINIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 4 | 0 |
DAPIROLIZUMAB PEGOL | CD40LG | Antibody | INHIBITOR | CD40 ligand inhibitor | 3 | 0 |
DINOPROSTONE | PTGER1 | Small molecule | AGONIST | Prostaglandin E2 receptor agonist | 4 | 0 |
FGF401 | FGFR4 | Small molecule | INHIBITOR | Fibroblast growth factor receptor 4 inhibitor | 2 | 0 |
AT-1501 | CD40LG | Unknown | INHIBITOR | CD40 ligand inhibitor | 2 | 0 |
RUPLIZUMAB | CD40LG | Antibody | INHIBITOR | CD40 ligand inhibitor | 3 | 0 |
BRIVANIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 3 | 0 |
NINTEDANIB ESYLATE | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 4 | 0 |
XL-999 | PDGFRB | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 2 | 0 |
TIROFIBAN HYDROCHLORIDE | ITGB3 | Small molecule | INHIBITOR | Integrin alpha-IIb/beta-3 inhibitor | 4 | 0 |
RAVAGALIMAB | CD40LG | Antibody | ANTAGONIST | CD40 ligand antagonist | 2 | 0 |
ROGARATINIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 2 | 0 |
AZD-4547 | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 2 | 0 |
ABCIXIMAB | ITGB3 | Antibody | INHIBITOR | Integrin alpha-V/beta-3 inhibitor | 4 | 0 |
INFIGRATINIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 4 | 2 |
INFIGRATINIB PHOSPHATE | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 4 | 0 |
NINTEDANIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 4 | 2 |
FUTIBATINIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 3 | 0 |
ORANTINIB | PDGFRB | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 3 | 0 |
VARLILUMAB | CD27 | Antibody | AGONIST | CD27 antigen agonist | 2 | 2 |
ONO-8539 | PTGER1 | Small molecule | ANTAGONIST | Prostanoid EP1 receptor antagonist | 2 | 0 |
DAZODALIBEP | CD40LG | Protein | ANTAGONIST | CD40 ligand antagonist | 2 | 0 |
DERAZANTINIB | FGFR3 | Small molecule | INHIBITOR | Fibroblast growth factor receptor inhibitor | 2 | 0 |
EPTIFIBATIDE | ITGB3 | Protein | INHIBITOR | Integrin alpha-IIb/beta-3 inhibitor | 4 | 0 |
ENMD-981693 | PDGFRB | Small molecule | INHIBITOR | Platelet-derived growth factor receptor inhibitor | 2 | 0 |
TIROFIBAN | ITGB3 | Small molecule | INHIBITOR | Integrin alpha-IIb/beta-3 inhibitor | 4 | 0 |
Causal Flows
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation
may causally activates or deactivates a downstream regulator
which then might up- or down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows for Regulon R-842
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|